Bill > HR1947

This bill, known as the "TREAT PTSD Act," directs the Departments of Veterans Affairs (VA) and Defense (DOD) to provide stellate ganglion block (SGB), a medical procedure involving an injection into nerve clusters in the neck, to veterans and active-duty military personnel diagnosed with post-traumatic stress disorder (PTSD). Under the bill, eligible veterans must be enrolled in the VA patient system and have been diagnosed with PTSD, while eligible service members must be enrolled in the TRICARE health program and have a PTSD diagnosis. In both cases, patients must be informed of the risks and benefits of SGB and voluntarily elect to receive the treatment. The bill requires the VA and DOD to update their joint clinical practice guideline for PTSD management within 180 days to reflect SGB as a therapy option and provide information about clinical indicators and contraindications. The medical treatment can be provided either through VA or DOD medical facilities or through qualified healthcare providers participating in their respective healthcare systems. The provisions will take effect 180 days after the bill's enactment, aiming to provide an additional treatment option for those struggling with PTSD.

Health and Social Services, Military Affairs and Security

https://www.congress.gov/bill/119th-congress/house-bill/1947/all-info